GB9918912D0 - New stilbenes with vascular damaging activity - Google Patents
New stilbenes with vascular damaging activityInfo
- Publication number
- GB9918912D0 GB9918912D0 GBGB9918912.8A GB9918912A GB9918912D0 GB 9918912 D0 GB9918912 D0 GB 9918912D0 GB 9918912 A GB9918912 A GB 9918912A GB 9918912 D0 GB9918912 D0 GB 9918912D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- stilbenes
- new
- vascular damaging
- damaging activity
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000000254 damaging effect Effects 0.000 title 1
- 150000001629 stilbenes Chemical class 0.000 title 1
- 235000021286 stilbenes Nutrition 0.000 title 1
- 230000002792 vascular Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/12—Esters of phosphoric acids with hydroxyaryl compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9918912.8A GB9918912D0 (en) | 1999-08-12 | 1999-08-12 | New stilbenes with vascular damaging activity |
CA002379544A CA2379544A1 (en) | 1999-08-12 | 2000-08-09 | New stilbenes with vascular damaging activity |
EP00951727A EP1206429A2 (en) | 1999-08-12 | 2000-08-09 | Stilbenes with vascular damaging activity |
NZ517069A NZ517069A (en) | 1999-08-12 | 2000-08-09 | New stilbenes with vascular damaging activity |
PCT/GB2000/003067 WO2001012579A2 (en) | 1999-08-12 | 2000-08-09 | New stilbenes with vascular damaging activity |
JP2001516880A JP2003507356A (en) | 1999-08-12 | 2000-08-09 | New stilbenes with vascular damage activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9918912.8A GB9918912D0 (en) | 1999-08-12 | 1999-08-12 | New stilbenes with vascular damaging activity |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9918912D0 true GB9918912D0 (en) | 1999-10-13 |
Family
ID=10858950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9918912.8A Ceased GB9918912D0 (en) | 1999-08-12 | 1999-08-12 | New stilbenes with vascular damaging activity |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1206429A2 (en) |
JP (1) | JP2003507356A (en) |
CA (1) | CA2379544A1 (en) |
GB (1) | GB9918912D0 (en) |
NZ (1) | NZ517069A (en) |
WO (1) | WO2001012579A2 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69931766T2 (en) * | 1998-04-03 | 2007-05-31 | Ajinomoto Co., Inc. | ANTITUMORAL AGENTS |
GB0019944D0 (en) * | 2000-08-15 | 2000-09-27 | Angiogene Pharm Ltd | Compositions with vascular damaging activity |
CA2432640A1 (en) | 2000-12-21 | 2002-06-27 | Cancer Research Technology Limited | Substituted stilbenes, their reactions and anticancer activity |
FR2838437B1 (en) | 2002-04-11 | 2004-06-04 | Aventis Pharma Sa | PROCESSES FOR THE PREPARATION OF COMBRETASTATINS |
GB0306908D0 (en) * | 2003-03-26 | 2003-04-30 | Angiogene Pharm Ltd | Bioreductively activated stilbene prodrugs |
EP1631540A4 (en) * | 2003-12-16 | 2006-10-04 | Gtx Inc | Prodrugs of selective androgen receptor modulators and methods of use thereof |
CN1723884A (en) | 2004-07-21 | 2006-01-25 | 中国人民解放军军事医学科学院放射医学研究所 | Cis-1, the diphenyl ethylene derivatives that 2-replaces are used to prepare the purposes of the medicine of treatment or prevent diabetes |
CN101085743B (en) * | 2006-06-06 | 2012-02-15 | 浙江大德药业集团有限公司 | Fluorine-containing alkoxy combretastatin derivative, preparation method and use thereof |
SI2219451T1 (en) | 2007-11-21 | 2015-02-27 | Oxigene, Inc. | Method for treating hematopoietic neoplasms |
JP2011016777A (en) * | 2009-07-10 | 2011-01-27 | Nipro Corp | New cysteine derivative |
WO2012025638A1 (en) | 2010-08-27 | 2012-03-01 | Universität des Saarlandes | Selective 17beta-hydroxysteroid dehydrogenase type 1 inhibitors |
US9353150B2 (en) | 2012-12-04 | 2016-05-31 | Massachusetts Institute Of Technology | Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment |
AU2014228822A1 (en) | 2013-03-15 | 2015-10-01 | Memorial Sloan-Kettering Cancer Center | HSP90-targeted cardiac imaging and therapy |
US11419934B2 (en) | 2015-08-18 | 2022-08-23 | Oncotelic Therapeutics, Inc. | Use of VDAS to enhance immunomodulating therapies against tumors |
WO2017197045A1 (en) | 2016-05-11 | 2017-11-16 | Movassaghi Mohammad | Convergent and enantioselective total synthesis of communesin analogs |
US11932650B2 (en) | 2017-05-11 | 2024-03-19 | Massachusetts Institute Of Technology | Potent agelastatin derivatives as modulators for cancer invasion and metastasis |
US10640508B2 (en) | 2017-10-13 | 2020-05-05 | Massachusetts Institute Of Technology | Diazene directed modular synthesis of compounds with quaternary carbon centers |
CN113227398A (en) | 2018-10-29 | 2021-08-06 | 塞弗德公司 | Exponential-base-3 nucleic acid amplification with nested overlapping primers at reduced amplification time |
US11535634B2 (en) | 2019-06-05 | 2022-12-27 | Massachusetts Institute Of Technology | Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9106177D0 (en) * | 1991-03-22 | 1991-05-08 | Aston Molecules Ltd | Substituted diphenylethylenes and analogues or derivatives thereof |
TW325458B (en) * | 1993-09-08 | 1998-01-21 | Ajinomoto Kk | Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer |
US5561122A (en) * | 1994-12-22 | 1996-10-01 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Combretastatin A-4 prodrug |
GB9903403D0 (en) * | 1999-02-16 | 1999-04-07 | Angiogene Pharm Ltd | Substituted stilbene compounds with vascular damaging activity |
-
1999
- 1999-08-12 GB GBGB9918912.8A patent/GB9918912D0/en not_active Ceased
-
2000
- 2000-08-09 WO PCT/GB2000/003067 patent/WO2001012579A2/en not_active Application Discontinuation
- 2000-08-09 EP EP00951727A patent/EP1206429A2/en not_active Withdrawn
- 2000-08-09 CA CA002379544A patent/CA2379544A1/en not_active Abandoned
- 2000-08-09 JP JP2001516880A patent/JP2003507356A/en active Pending
- 2000-08-09 NZ NZ517069A patent/NZ517069A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001012579A3 (en) | 2001-10-11 |
NZ517069A (en) | 2004-04-30 |
EP1206429A2 (en) | 2002-05-22 |
WO2001012579A2 (en) | 2001-02-22 |
CA2379544A1 (en) | 2001-02-22 |
JP2003507356A (en) | 2003-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9918912D0 (en) | New stilbenes with vascular damaging activity | |
IL186608A0 (en) | Igf-like insulin variant | |
IL152682A0 (en) | Indole derivatives with vascular damaging activity | |
HUP0300290A3 (en) | Combination therapies with vascular damaging activity | |
SG93875A1 (en) | Showcase | |
GB9922610D0 (en) | Improved showcase | |
EP1296704A4 (en) | Peptides with physiological activity | |
GB0009753D0 (en) | Dishwasher with removable basket | |
HK1047940A1 (en) | 9A-azalides with antibacterial activity | |
GB2356555B (en) | Dishwasher | |
SG87161A1 (en) | Absorptive article | |
HUP0300576A3 (en) | Divided dose therapies with vascular damaging activity | |
GB9927711D0 (en) | Vascular occluder | |
GB2356131B (en) | Dishwasher | |
GB2358390B (en) | Storage assembly | |
GB2351756B (en) | Trellis assemblies | |
GB9921764D0 (en) | Syringe | |
GB0027081D0 (en) | Solution | |
SI1272200T1 (en) | Divided dose therapies with vascular damaging activity | |
TW369844U (en) | Modified shelf structure | |
TW404218U (en) | Dish structure | |
CA85594S (en) | Syringe | |
TW386417U (en) | Juicer structure | |
PL336556A1 (en) | Case with drawers | |
ZA99106B (en) | Vascular damaging agents. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |